Showing results (1-10 of 3,176) with videos related to
Sort By:
Pageof 318
BMJ (Clinical Research Ed.)|January 25, 1997
Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)R Rai, H Cohen, M Dave, et al.British Journal of Haematology|February 1, 1996
Second-trimester pregnancy loss is associated with activated C resistanceR Rai, L Regan, E Hadley, et al.Current Opinion in Obstetrics & Gynecology|January 13, 1998
Obstetric complications of antiphospholipid antibodiesR Rai, L ReganSeminars in Reproductive Medicine|May 18, 2001
Thrombophilia and adverse pregnancy outcomeR Rai, L ReganCurrent Opinion in Obstetrics & Gynecology|August 1, 1997
Antiphospholipid antibodies, infertility and recurrent miscarriageR Rai, L ReganHospital Medicine (London, England : 1998)|November 26, 1998
Antiphospholipid syndrome and pregnancy lossR Rai, L ReganBailliere'S Best Practice & Research. Clinical Obstetrics & Gynaecology|October 12, 2000
Epidemiology and the medical causes of miscarriageL Regan, R RaiBritish Journal of Obstetrics and Gynaecology|July 30, 1999
Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparinM Backos, R Rai, N Baxter, et al.Human Reproduction (Oxford, England)|May 2, 2001
Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriageR Rai, A Shlebak, H Cohen, et al.Fertility and Sterility|February 26, 2000
Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilizationI T Chilcott, R Margara, H Cohen, et al.Pageof 318